NIH-funded research R21 grant

Understanding how HIV hides and how to wake it up

Official title: Novel Epigenetic Marks for HIV Latency Entry and Reversal

Funded at Univ of North Carolina Chapel Hill · NIH-10885922 · Data updated 2026-11-12

This study is looking at how HIV can hide in the body and is exploring new ways to wake it up so it can be treated, which could help people living with HIV find better therapies in the future.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startJuly 11, 2023
Project endJune 30, 2025
Funding year2024
Award (this year)$194,375
NIH project number5R21AI167709-02
Project IDNIH-10885922 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals living with HIV who have developed latent infections and are seeking new treatment options.

Less likely to help

Patients who are not infected with HIV or those who have advanced AIDS may not benefit from this research.

What this research studies

This research investigates the mechanisms that allow HIV to remain dormant in the body and explores new ways to activate the virus for treatment. By focusing on epigenetic changes, particularly the role of crotonylation, the study aims to identify how these modifications can influence HIV transcription and latency. The researchers will analyze the chromatin structure around the HIV promoter to develop strategies that could potentially eliminate hidden HIV reservoirs. Patients may benefit from insights that could lead to more effective therapies for HIV.

Why it matters

Potential benefit: If successful, this research could lead to breakthroughs in eradicating latent HIV reservoirs, improving treatment outcomes for patients living with HIV.

How similar studies have gone: Previous research has shown promise in targeting HIV latency through epigenetic modifications, indicating that this approach may lead to significant advancements in treatment.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Jiang, Guochun — Univ of North Carolina Chapel Hill
  • Study coordinator: Jiang, Guochun

Related research

Other NIH-funded projects on the same topics.

  • A center for coordinating data related to heart and blood health.

    This study is working on a new system to gather and analyze health information about heart and blood disorders, which could lead to better ways to diagnose and treat these conditions, ultimately helping patients like you.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-9732880

  • Healthy work design and worker well-being

    A multi-site program aims to improve the health and well-being of workers by studying how work design affects safety, stress, and quality of life.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11631666

  • Unified and fair multimodal learning for autoimmune diseases

    A patient-friendly AI approach will combine many kinds of health data to improve diagnosis and personalized care for autoimmune diseases, including lupus.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11625649

  • Structural factors linking minimum wage, COVID-19, and community violence

    A long-term study will explore whether higher minimum wages and pandemic-related economic factors are connected to changes in violence in US communities.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11624218

  • Non-invasive tears biomarker for early Alzheimer's in LMICs

    A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11623923

  • How HPV interacts with our cells' DNA damage system and its effect on cancer

    This project looks at how high-risk HPV uses the body’s DNA repair machinery to replicate and potentially drive cancer, with the goal of finding new antiviral and cancer-fighting approaches for people affected by HPV-related diseases.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11622604

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.